BIOGEN INC.
Biogen Inc. is a global biopharmaceutical company that focuses on discovering, developing, and delivering innovative therapies for people living with serious and complex diseases, primarily in the areas of neurology, neuropsychiatry, and rare diseases. The company's marketed products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, FAMPYRA, SPINRAZA, QALSODY, FUMADERM, and SKYCLARYS for the treatment of multiple sclerosis, Alzheimer's disease, severe plaque psoriasis, spinal muscular atrophy, Friedreich's Ataxia, and other conditions. Biogen also markets biosimilars of advanced biologics such as BENEPALI, IMRALDI, FLIXABI, and BYOOVIZ in certain countries in Europe and BYOOVIZ in the U.S. and certain international markets. The company collaborates with various partners, including Eisai, Sage Therapeutics, and Alkermes, to develop and commercialize their products. Biogen's website is www.biogen.com, and its stock ticker is BIIB.